Jane Street Group, LLC T2 Biosystems, Inc. Transaction History

Jane Street Group, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.09 - $565.0 $22,292 - $140 Million	247,698 New	247,698 $28,000
Q2 2022 Aug 16, 2022	SELL	$0.15 - $0.54 $4,407 - $15,865	-29,381 Closed	0 $0
Q1 2022 May 17, 2022	SELL	$0.36 - $0.57 $22,237 - $35,210	-61,772 Reduced 67.77%	29,381 $15,000
Q4 2021 Feb 15, 2022	SELL	$0.46 - $0.94 $8,604 - $17,582	-18,705 Reduced 17.03%	91,153 $47,000
Q2 2021 Aug 16, 2021	BUY	$1.04 - $1.69 $114,252 - $185,660	109,858 New	109,858 $131,000
Q3 2020 Nov 17, 2020	SELL	$1.15 - $2.1 $53,471 - $97,643	-46,497 Closed	0 $0
Q2 2020 Aug 17, 2020	BUY	$0.48 - $1.67 $22,318 - $77,649	46,497 New	46,497 $59,000
Q3 2019 Nov 14, 2019	SELL	$0.58 - $3.01 $108,967 - $565,503	-187,875 Closed	0 $0
Q2 2019 Aug 15, 2019	BUY	$1.47 - $3.16 $276,176 - $593,685	187,875 New	187,875 $316,000
Q1 2019 May 16, 2019	SELL	$2.56 - $4.48 $57,244 - $100,177	-22,361 Closed	0 $0
Q4 2018 Feb 15, 2019	BUY	$2.98 - $6.86 $66,635 - $153,396	22,361 New	22,361 $67,000

Ticker TTOO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 7,050,850
Market Cap $3.38M
Description
T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fl...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.